Drew Moghanaki: Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X:

“It’s been nearly a decade since along with Joe Y Chang we celebrated the fortitude of thoracic surgeons who were the first physicians in history to provide a curative treatment for patients with lung cancer.”

Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Authors: Drew Moghanaki, Joe Y. Chang

Drew Moghanaki

Drew Moghanaki: Is surgery still the optimal treatment for stage I non-small cell lung cancer?

“It’s been nearly a decade since along with Joe Y Chang we celebrated the fortitude of thoracic surgeons who were the first physicians in history to provide a curative treatment for patients with lung cancer.”